Thrombocytosis is a marker of reduced survival in patients with renal cell carcinoma.: A multicenter study. Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante, [S. l.], v. 10, n. 1, p. 43–48, 2022. DOI: 10.56867/11. Disponível em: https://www.rev-sen.ec/index.php/revista/article/view/11. Acesso em: 16 apr. 2026.